The dopamine agonist apomorphine differentially affects cognitive performance in alcohol dependent patients and healthy controls (English)
- New search for: Schellekens, A. F.
- New search for: van Oosterwijck, A. W.
- New search for: Ellenbroek, B.
- New search for: de Jong, C. A.
- New search for: Buitelaar, J. K.
- New search for: Cools, L.
- New search for: Verkes, R. J.
- New search for: Schellekens, A. F.
- New search for: van Oosterwijck, A. W.
- New search for: Ellenbroek, B.
- New search for: de Jong, C. A.
- New search for: Buitelaar, J. K.
- New search for: Cools, L.
- New search for: Verkes, R. J.
In:
EUROPEAN NEUROPSYCHOPHARMACOLOGY
;
19
, 1
;
68-73
;
2009
-
ISSN:
- Article (Journal) / Print
-
Title:The dopamine agonist apomorphine differentially affects cognitive performance in alcohol dependent patients and healthy controls
-
Contributors:Schellekens, A. F. ( author ) / van Oosterwijck, A. W. ( author ) / Ellenbroek, B. ( author ) / de Jong, C. A. ( author ) / Buitelaar, J. K. ( author ) / Cools, L. ( author ) / Verkes, R. J. ( author )
-
Published in:EUROPEAN NEUROPSYCHOPHARMACOLOGY ; 19, 1 ; 68-73
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2009-01-01
-
Size:6 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.8 / 615.1
- Further information on Dewey Decimal Classification
-
Classification:
-
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 19, Issue 1
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
BL-1020: A novel antipsychotic drug with GABAergic activity and low catalepsy, is efficacious in a rat model of schizophreniaGeffen, Y. / Nudelman, A. / Gil-Ad, I. / Rephaeli, A. / Huang, M. / Savitsky, K. / Klapper, L. / Winkler, I. / Meltzer, H. Y. / Weizman, A. et al. | 2009
- 14
-
Improvement of aggressive behavior and quality of life impairment following S-Adenosyl-Methionine (SAM-e) augmentation in schizophreniaStrous, R. D. / Ritsner, M. S. / Adler, S. / Ratner, Y. / Maayan, R. / Kotler, M. / Lachman, H. / Weizman, A. et al. | 2009
- 23
-
Blockade of dopamine D3 receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: Similar actions of D1 receptor agonists, but not of D2 antagonistsLoiseau, F. / Millan, M. J. et al. | 2009
- 34
-
Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDDPapakostas, G. I. / Fava, M. et al. | 2009
- 41
-
Antidepressants alleviate the impact of reinforcer downshiftNikiforuk, A. / Popik, P. et al. | 2009
- 49
-
Neurosteroid blood levels in delinquent adolescent boys with conduct disorderGolubchik, P. / Mozes, T. / Maayan, R. / Weizman, A. et al. | 2009
- 53
-
Dopaminergic and serotonergic activity in neostriatum and nucleus accumbens enhanced by intranasal administration of testosteronede Souza Silva, M. A. / Mattern, C. / Topic, B. / Buddenberg, T. E. / Huston, J. P. et al. | 2009
- 64
-
Interaction between SERTPR and stressful life events on response to antidepressant treatmentMandelli, L. / Marino, E. / Pirovano, A. / Calati, R. / Zanardi, R. / Colombo, C. / Serretti, A. et al. | 2009
- 68
-
The dopamine agonist apomorphine differentially affects cognitive performance in alcohol dependent patients and healthy controlsSchellekens, A. F. / van Oosterwijck, A. W. / Ellenbroek, B. / de Jong, C. A. / Buitelaar, J. K. / Cools, L. / Verkes, R. J. et al. | 2009
- 74
-
Zolpidem-induced amnesia and somnambulism: Rare occurrences?Tsai, J. H. / Yang, P. / Chen, C. C. / Chung, W. / Tang, T. C. / Wang, S. Y. / Liu, J. K. et al. | 2009
-
ECNP Calendar of Meetings| 2009
-
ECNP Announcement: 22nd ECNP Congress| 2009
-
Editorial Board| 2009
-
Contents| 2009